Form 4 for PMCB PharmaCyte Biotech, Inc.
Accepted 2025-12-12 00:00:00 ET · period of report 2025-04-25 · accession 0001683168-25-009116 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-12-12 | 2025-12-12 | PMCB | WEINSTEIN ROBERT | Dir | A - Grant | $0.00 | +75.0K | 75.0K | New | $0 |
| D | 2025-12-12 | 2025-12-12 | PMCB | WEINSTEIN ROBERT | Dir | F - Tax | $1.02 | -33.8K | 41.2K | -45% | -$34.4K |
| D | 2025-12-12 | 2025-04-25 | PMCB | WEINSTEIN ROBERT | Dir | A - Grant | $0.00 | +63.2K | 63.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-12-12 | A | A | 75,000 | $0.00 | 75,000 | D | — | — | |
| 2 | Common | Common Stock | 2025-12-12 | F | D | 33,750 | $1.02 | 41,250 | D | — | — | (F1) Represents shares withheld by the Issuer to satisfy the tax liability upon vesting of restricted stock units and does not constitute an actual sale or other open-market transaction. |
| 3 | Derivative | Stock Option (Right to Buy) | 2025-04-25 | A | A | 63,233 | $0.00 | 63,233 | D | $1.22 · — to 2035-04-24 | 63,233 Common Stock | (F2) The options shall vest in full on the date of the Issuer's next annual meeting of stockholders, subject to the continued service of Mr. Weinstein. This transaction is late due to an inadvertent administrative error and not any error of Mr. Weinstein. |